Detalles de la búsqueda
1.
Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
Am Heart J
; 155(2): 382-7, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18215612
2.
Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
Thromb Haemost
; 95(3): 447-53, 2006 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16525572
3.
Comparable pharmacokinetics and pharmacodynamics of melagatran in Japanese and caucasian volunteers after oral administration of the direct thrombin inhibitor ximelagatran.
Clin Pharmacokinet
; 45(1): 85-94, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16430313
4.
Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial.
Lancet
; 362(9386): 789-97, 2003 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-13678873
5.
Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery : Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety.
Clin Drug Investig
; 25(1): 65-77, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-17523747
6.
Clinical imaging in anti-atherosclerosis drug development.
Drug Discov Today
; 20(11): 1317-27, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26151479
7.
A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.
Thromb Haemost
; 87(2): 231-7, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11858482
8.
Sustained heparin effect contributes to reduced plasma thrombin generation capacity early after cardiac surgery.
Thromb Res
; 130(5): 769-74, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22261474
9.
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.
Thromb Res
; 127(2): 91-9, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21172721
10.
Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study.
Thromb Res
; 126(2): e128-33, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20580414
11.
Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
Eur Heart J
; 28(6): 692-8, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17314111
12.
Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty.
Pathophysiol Haemost Thromb
; 35(6): 428-34, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17565235
13.
Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial.
Lancet
; 360(9344): 1441-7, 2002 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-12433510
Resultados
1 -
13
de 13
1
Próxima >
>>